L. Suivi-des-patients-après-traitement and .. , 94 A-Quand obtient-on la meilleure réponse?, p.94

L. Paramètres-de-quantification-usuels, .. Le, and S. , 112 a) Valeur de fixation normalisée 113 b) Le volume tumoral métabolique, p.115

.. Index-glycolytique-totale, 115 d) Normalisation à la fixation hépatique, p.116

I. But-de-l-'étude and .. , 120 A-Objectif principal, p.120

I. Matériels and M. , 121 A-Patients et réalisation de l'étude, p.121

S. Grabar, D. Costagliola, and A. Bouvier, NB : la flèche blanche sur le TEP pré-traitement correspond à une atteinte inguinale REFERENCES 1 Epidémiologie du cancer de l'anus, pp.251-258

V. Vendrely, A. Rullier, and C. Laurent, Prise en charge du cancer du canal anal, EMC -­? Gastro-­? entérologie, vol.8, issue.2, pp.1-17, 2013.

B. Kim, I. Kim, S. Kim, H. Nam, K. Pak et al., The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT, Nuclear Medicine and Molecular Imaging, vol.52, issue.1, pp.36-42, 2011.
DOI : 10.1007/s13139-010-0062-8

R. Lim, A. Eaton, N. Lee, J. Setton, N. Ohri et al., 18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma, Journal of Nuclear Medicine, vol.53, issue.10, pp.1506-1519, 2012.
DOI : 10.2967/jnumed.111.101402

J. Schwarz, B. Siegel, F. Dehdashti, R. Myerson, J. Fleshman et al., Tumor Response and Survival Predicted by Post-Therapy FDG-PET/CT in Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.1, pp.180-186, 2008.
DOI : 10.1016/j.ijrobp.2007.09.005

M. Mistrangelo, E. Pelosi, M. Bellò, U. Ricardi, E. Milanesi et al., Role of Positron Emission Tomography-Computed Tomography in the Management of Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.1, pp.66-72, 2012.
DOI : 10.1016/j.ijrobp.2011.10.048

J. Bazan, A. Koong, D. Kapp, A. Quon, E. Graves et al., Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal, Journal of Nuclear Medicine, vol.54, issue.1, pp.27-32, 2013.
DOI : 10.2967/jnumed.112.109470

E. Kidd, F. Dehdashti, B. Siegel, and P. Grigsby, Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis, Radiotherapy and Oncology, vol.95, issue.3
DOI : 10.1016/j.radonc.2010.02.019

M. Clark, A. Hartley, and J. Geh, Cancer of the anal canal, The Lancet Oncology, vol.5, issue.3, pp.149-57, 2004.
DOI : 10.1016/S1470-2045(04)01410-X

. Barth-x, E. Tissot, and O. Monneuse, Anatomie chirurgicale de la r??gion anale, EMC - Techniques chirurgicales - Appareil digestif, vol.4, issue.3, pp.40-680, 2009.
DOI : 10.1016/S0246-0424(09)39744-7

1. Gastrointestinal, ­?FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development, Eur Radiol, vol.19, issue.9, pp.2171-2180, 2009.

R. Tatlidil, H. Jadvar, J. Bading, and P. Conti, Incidental Colonic Fluorodeoxyglucose Uptake: Correlation with Colonoscopic and Histopathologic Findings, Radiology, vol.224, issue.3, 2002.
DOI : 10.1148/radiol.2243011214

M. Abouzied, E. Crawford, and H. Nabi, 18F-­?FDG imaging: pitfalls and artifacts, J Nucl

S. Rosenbaum, T. Lind, G. Antoch, and A. Bockisch, False-Positive FDG PET Uptake???the Role of PET/CT, European Radiology, vol.30, issue.4, pp.1054-65, 2006.
DOI : 10.1007/s00330-005-0088-y

A. Grulich, I. Poynten, D. Machalek, J. F. Templeton, D. Hillman et al., The epidemiology of anal cancer, Sexual Health, vol.9, issue.6, p.504, 2012.
DOI : 10.1071/SH12070

I. Sobhani, Cancer anal : de l'épidémiologie au traitement [Internet], 2002.

S. Vieillot and D. Azria, Prise en charge du cancer épidermoïde du canal anal. FMC-­?HGE, 2013.

M. Curado and B. Edwards, Cancer Incidence in Five Continents, IX. IARC Scientific Publication

D. Ryan, C. Compton, and R. Mayer, Carcinoma of the Anal Canal, New England Journal of Medicine, vol.342, issue.11, pp.792-800, 2000.
DOI : 10.1056/NEJM200003163421107

L. John and J. Young, Catalog Record: Surveillance, epidemiology, and end results :... | Hathi Trust Digital Library [Internet], 1981.

R. Doll, D. Parkin, and . Maxwell, International Agency for Research on Cancer. Cancer incidence in five continents 8. 8. Lyon, 2002.

M. Melbye, C. Rabkin, M. Frisch, and R. Biggar, Changing Patterns of Anal Cancer Incidence in the United States, 1940???1989, American Journal of Epidemiology, vol.139, issue.8, pp.772-80, 1994.
DOI : 10.1093/oxfordjournals.aje.a117073

A. Nielsen, C. Munk, and S. Kjaer, Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008, International Journal of Cancer, vol.124, issue.10 Suppl, pp.1168-73, 2012.
DOI : 10.1002/ijc.26115

S. Goldman, B. Glimelius, B. Nilsson, and L. Påhlman, Incidence of anal epidermoid carcinoma in Sweden 1970-­?1984, Acta Chir Scand, vol.155, issue.3, pp.191-198, 1989.

D. Robinson, V. Coupland, and H. Møller, An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England, British Journal of Cancer, vol.62, issue.3, 2009.
DOI : 10.1016/0304-419X(96)00020-0

A. Nielsen, C. Munk, and S. Kjaer, Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008, International Journal of Cancer, vol.124, issue.10 Suppl, pp.1168-73, 2012.
DOI : 10.1002/ijc.26115

D. Brewster and L. Bhatti, Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975???2002, British Journal of Cancer, vol.31, issue.1, pp.87-90, 1975.
DOI : 10.1023/B:CACO.0000003837.10664.7f

R. Cress and E. Holly, Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973???1999??????This research was supported in part by the Centers for Disease Control National Program of Cancer Registries, Grant U75/CCU910677, and by the National Cancer Institute, Grants R01 CA54053, R01 CA63933, and R01 CA88739., Preventive Medicine, vol.36, issue.5, pp.555-60, 2003.
DOI : 10.1016/S0091-7435(03)00013-6

F. Martin, D. Kavanagh, and R. Waldron, Squamous cell carcinoma of the anal canal. The Surgeon, pp.232-239, 2009.

S. Zaki, R. Judd, L. Coffield, P. Greer, F. Rolston et al., Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction, Am J Pathol, vol.140, issue.6, pp.1345-55, 1992.

P. Howley, On Human Papillomaviruses, New England Journal of Medicine, vol.315, issue.17, pp.1089-90, 1986.
DOI : 10.1056/NEJM198610233151710

M. Duggan, V. Boras, M. Inoue, S. Mcgregor, and D. Robertson, Hybridization, American Journal of Clinical Pathology, vol.92, issue.1, pp.16-21, 1989.
DOI : 10.1093/ajcp/92.1.16

G. Williams, Q. Lu, S. Love, I. Talbot, and J. Northover, PROPERTIES OF HPV-POSITIVE AND HPV-NEGATIVE ANAL CARCINOMAS, The Journal of Pathology, vol.55, issue.4, pp.378-82, 1996.
DOI : 10.1002/(SICI)1096-9896(199612)180:4<378::AID-PATH697>3.0.CO;2-H

D. Vuyst, H. Clifford, G. Nascimento, M. Madeleine, M. Franceschi et al., Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis, International Journal of Cancer, vol.50, issue.7, pp.1626-1662, 2009.
DOI : 10.1002/ijc.24116

M. Shiels, R. Pfeiffer, A. Chaturvedi, A. Kreimer, and E. Engels, Impact of the HIV Epidemic on the Incidence Rates of Anal Cancer in the United States, JNCI Journal of the National Cancer Institute, vol.104, issue.20
DOI : 10.1093/jnci/djs371

M. Guiguet, F. Boué, J. Cadranel, J. Lang, E. Rosenthal et al., Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study, The Lancet Oncology, vol.10, issue.12, 2009.
DOI : 10.1016/S1470-2045(09)70282-7

E. Lanoy, J. Spano, F. Bonnet, M. Guiguet, F. Boué et al., The spectrum of malignancies in HIV-infected patients in 2006 in France: The ONCOVIH study, International Journal of Cancer, vol.45, issue.2
DOI : 10.1002/ijc.25903

M. Stanley, Pathology and epidemiology of HPV infection in females, Gynecologic Oncology, vol.117, issue.2, pp.5-10, 2010.
DOI : 10.1016/j.ygyno.2010.01.024

L. Johnson, M. Madeleine, L. Newcomer, S. Schwartz, and J. Daling, Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, 1973-2000, Cancer, vol.13, issue.2, pp.281-289, 2004.
DOI : 10.1002/cncr.20364

J. Ajani and . Fluorouracil, Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, 2008.
DOI : 10.1001/jama.299.16.1914

F. Greene, D. Page, and I. Fleming, AJCC Cancer Staging ManualAmericain Joint Committee on Cancer, 2002.

C. Adam and T. Petit, Memento de pathologie, pp.105-114, 2006.

M. Brady, J. Kavolius, and S. Quan, Anorectal melanoma, Diseases of the Colon & Rectum, vol.38, issue.2, pp.146-51, 1995.
DOI : 10.1007/BF02052442

C. Lobry and L. Abramowitz, L??sions pr??n??oplasiques de l'anus, Gastro-­?entérologie, 9-­?084-­?E-­?10, 2010.
DOI : 10.1016/S1155-1968(10)53131-6

J. Monsonego, Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin. Gynécologie Obstétrique Fertil, pp.250-254, 2010.

R. Glynne-­?jones, Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.25, issue.suppl 3, 2014.
DOI : 10.1093/annonc/mdu159

T. Hong, J. Chin, and J. Wo, Anal cancer: current and future treatment strategies, Gastrointestinal Cancer: Targets and Therapy
DOI : 10.2147/GICTT.S25844

S. Saboo, K. Zukotynski, A. Shinagare, K. Krajewski, and N. Ramaiya, Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up, Abdominal Imaging, vol.21, issue.1, pp.728-763, 2013.
DOI : 10.1007/s00261-012-9958-3

P. Grigsby, . Fdg-­?pet-/, and . Ct, FDG-PET/CT: New horizons in anal cancer, Gastroent??rologie Clinique et Biologique, vol.33, issue.5, pp.456-464, 2009.
DOI : 10.1016/j.gcb.2009.01.012

C. Caldarella, S. Annunziata, G. Treglia, R. Sadeghi, N. Ayati et al., Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis, The Scientific World Journal, vol.12, issue.1, pp.1-11, 2014.
DOI : 10.1016/j.ijrobp.2010.05.050

J. Sveistrup, A. Loft, A. Berthelsen, B. Henriksen, M. Nielsen et al., Positron Emission Tomography/Computed Tomography in the Staging and Treatment of Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.1
DOI : 10.1016/j.ijrobp.2011.06.1955

E. Winton, . De, A. Heriot, M. Ng, R. Hicks et al., The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, British Journal of Cancer, vol.140, issue.5, pp.693-700, 2009.
DOI : 10.1016/S0140-6736(96)03409-5

I. Wells and B. Fox, PET/CT in anal cancer ? is it worth doing? Clin Radiol, 2012.

N. Bhuva, R. Glynne-­?jones, L. Sonoda, W. Wong, and M. Harrison, To PET or not to PET? That is the question. Staging in anal cancer, Annals of Oncology, vol.23, issue.8, pp.2078-82, 2012.
DOI : 10.1093/annonc/mdr599

M. Mistrangelo, E. Pelosi, M. Bellò, I. Castellano, P. Cassoni et al., Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node Metastases in Patients With Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.1, pp.73-81, 2010.
DOI : 10.1016/j.ijrobp.2009.04.020

A. Engledow, J. Skipworth, G. Blackman, A. Groves, J. Bomanji et al., The role of 18 fluoro-­?deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma, Colorectal Dis Off J Assoc Coloproctology G B Irel, vol.13, issue.5, pp.532-539, 2011.

A. Benson, P. Arnoletti, and E. Chan, Anal Carcinoma, Version 2

M. Krengli, M. Milia, L. Turri, E. Mones, M. Bassi et al., FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma, Radiation Oncology, vol.5, issue.1, p.10, 2010.
DOI : 10.1186/1748-717X-5-10

N. Nigro, V. Vaitkevicius, and B. Considine, Combined therapy for cancer of the anal canal, Diseases of the Colon & Rectum, vol.17, issue.3, pp.354-360, 1974.
DOI : 10.1007/BF02586980

M. Flam, M. John, T. Pajak, N. Petrelli, R. Myerson et al., Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study., Journal of Clinical Oncology, vol.14, issue.9, pp.2527-2566, 1996.
DOI : 10.1200/JCO.1996.14.9.2527

F. Lim and R. Glynne-­?jones, Chemotherapy/chemoradiation in anal cancer: A systematic review, Cancer Treatment Reviews, vol.37, issue.7, pp.520-552, 2011.
DOI : 10.1016/j.ctrv.2011.02.003

L. Gunderson, K. Winter, J. Ajani, J. Pedersen, J. Moughan et al., Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin, Journal of Clinical Oncology, vol.30, issue.35
DOI : 10.1200/JCO.2012.43.8085

R. Glynne-­?jones, R. James, and H. Meadows, Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU insquamous celle carcinoma of the anus: Results of ACT II, J Clin Oncol, vol.30, issue.15, p.2012

D. Weber, J. Kurtz, and A. Allal, The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.50, issue.3, pp.675-80, 2001.
DOI : 10.1016/S0360-3016(01)01510-3

A. Konski, M. Garcia, M. John, R. Krieg, W. Pinover et al., Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.1
DOI : 10.1016/j.ijrobp.2007.12.027

L. Kachnic, K. Winter, R. Myerson, M. Goodyear, J. Willins et al., RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.1, pp.27-33, 2013.
DOI : 10.1016/j.ijrobp.2012.09.023

L. Kachnic, K. Winter, and R. Myerson, Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal., Journal of Clinical Oncology, vol.29, issue.4_suppl, p.368, 2011.
DOI : 10.1200/jco.2011.29.4_suppl.368

J. Bazan, W. Hara, A. Hsu, P. Kunz, J. Ford et al., Intensity-­?modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer, pp.3342-51, 2011.

T. S. Hong and J. L. Pretz, ACR Appropriateness Criteria®-­?Anal Cancer Expert Panel on Radiation Oncology-­?Rectal/Anal Cancer, Feb, 2014.

S. Cotter, P. Grigsby, B. Siegel, F. Dehdashti, R. Malyapa et al., FDG-PET/CT in the evaluation of anal carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.3, pp.720-725, 2006.
DOI : 10.1016/j.ijrobp.2006.01.009

D. Rouquie, P. Lasser, M. Castaing, V. Boige, D. Goéré et al., Complete (R0) resection is the only valid prognostic factor in abdominoperineal resection for recurrent cancer of the anal canal (a consecutive series of 95 patients)], J Chir, 2008.

J. Blumetti and A. Bastawrous, Epidermoid Cancers of the Anal Canal: Current Treatment, Clinics in Colon and Rectal Surgery, vol.22, issue.02
DOI : 10.1055/s-0029-1223838

J. Hépato, Oncologie Digestive -­? Echographie endo-­?anale et cancer du canal anal [Internet], 2014.

V. Lowe, J. Fletcher, L. Gobar, M. Lawson, P. Kirchner et al., Prospective investigation of positron emission tomography in lung nodules., Journal of Clinical Oncology, vol.16, issue.3, pp.1075-84, 1998.
DOI : 10.1200/JCO.1998.16.3.1075

E. Deutsch, Cancer du canal anal (cancer de l'anus) Cancerologie digestive TN, Thesaurus National de Cancerologie Digestive, pp.1-12, 2010.

O. Warburg, K. Posener, and E. Negelein, Ueber den Stoffwechsel der Carcinomzelle, Biochem. Z, vol.152, pp.309-344, 1924.

K. Kubota, R. Kubota, and S. Yamada, FDG accumulation in tumor tissue, J Nucl Med Off Publ Soc Nucl Med, vol.34, issue.3, pp.419-440, 1993.

F. Pet and P. /. Ct, EANM procedure guidelines for tumour PET imaging: version 1.0, Eur J

B. Nguyen, D. Joon, V. Khoo, G. Quong, M. Chao et al., Assessing the impact of FDG-­?PET in the management of anal cancer. Radiother Oncol, pp.376-82, 2008.

M. Mistrangelo, A. Lesc, and . Pet-­?ct-in, Anal Cancer: Indications and Limits Positron Emission Tomography -­? Recent Developments in Instrumentation, Research and Clinical Oncological Practice [Internet]. InTech Available from: http://www.intechopen.com/books/positron-­?emission-­?tomography-­?recent-­?developments-­? in-­?instrumentation, 2014.

P. Bannas, C. Weber, G. Adam, T. Frenzel, T. Derlin et al., Contrast-Enhanced [18F]fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Staging and Radiotherapy Planning in Patients With Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.2, 2011.
DOI : 10.1016/j.ijrobp.2010.05.050

A. Iagaru, R. Kundu, H. Jadvar, and D. Nagle, Evaluation by 18F-­?FDG-­?PET of patients with anal squamous cell carcinoma, Hell J Nucl Med, vol.12, issue.1, pp.26-35, 2009.

C. Anderson, M. Koshy, C. Staley, N. Esiashvili, S. Ghavidel et al., PET-CT Fusion in Radiation Management of Patients with Anorectal Tumors, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.1, 2007.
DOI : 10.1016/j.ijrobp.2007.02.055

P. Valk, . Bailey-dl, and . Townsend, Positron emission tomography.Basic science and clinical practice, 2003.

L. Vercellino, F. Montravers, V. De-parades, V. Huchet, K. Kerrou et al., Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma, International Journal of Colorectal Disease, vol.12, issue.1, 2011.
DOI : 10.1007/s00384-010-1080-9

M. Juweid and B. Cheson, Positron-Emission Tomography and Assessment of Cancer Therapy, New England Journal of Medicine, vol.354, issue.5, pp.496-507, 2006.
DOI : 10.1056/NEJMra050276

T. Beyer, J. Czernin, and L. Freudenberg, Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users, Journal of Nuclear Medicine, vol.52, issue.2, pp.303-313, 2011.
DOI : 10.2967/jnumed.110.079624

R. Wahl, H. Jacene, Y. Kasamon, and M. Lodge, From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, Journal of Nuclear Medicine, vol.50, issue.Suppl_1, pp.122-150, 2009.
DOI : 10.2967/jnumed.108.057307

M. Vanderhoek, S. Perlman, and R. Jeraj, Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response, Journal of Nuclear Medicine, vol.53, issue.1, pp.4-11, 2012.
DOI : 10.2967/jnumed.111.093443

P. Lee, J. Bazan, P. Lavori, D. Weerasuriya, A. Quon et al., Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-­?small-­?cell lung cancer. Clin Lung Cancer, pp.52-60, 2012.

I. Ciernik, E. Dizendorf, and B. Baumert, Radiation treatment planning with an integrtedpositron emission and computer tomography (PET-­?CT): a feasibility study, Int J Radiatopn Oncol Biol Phys, pp.853-863, 2003.

S. Larson, Y. Erdi, T. Akhurst, M. Mazumdar, H. Macapinlac et al., Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion Glycolysis, Clinical Positron Imaging, vol.2, issue.3
DOI : 10.1016/S1095-0397(99)00016-3

R. Boellaard, Standards for PET Image Acquisition and Quantitative Data Analysis, Journal of Nuclear Medicine, vol.50, issue.Suppl_1
DOI : 10.2967/jnumed.108.057182

N. Paquet, A. Albert, J. Foidart, and R. Hustinx, Within-­?patient variability of (18)F-­?FDG: standardized uptake values in normal tissues, J Nucl Med Off Publ Soc Nucl Med, 2004.

C. Capirci, D. Rubello, F. Pasini, F. Galeotti, E. Bianchini et al., The Role of Dual-Time Combined 18-Fluorideoxyglucose Positron Emission Tomography and Computed Tomography in the Staging and Restaging Workup of Locally Advanced Rectal Cancer, Treated With Preoperative Chemoradiation Therapy and Radical Surgery, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, 2009.
DOI : 10.1016/j.ijrobp.2008.10.064

A. Maffione, G. Grassetto, S. Chondrogiannis, P. Colletti, and D. Rubello, Quantitative PET Factors Predictive of the Response to Therapy in Solid Tumors, Clinical Nuclear Medicine
DOI : 10.1097/RLU.0000000000000319

T. Belhocine, A. Thille, V. Fridman, A. Albert, L. Seidel et al., Contribution of Whole-Body 18FDG PET Imaging in the Management of Cervical Cancer, Gynecologic Oncology, vol.87, issue.1, 2002.
DOI : 10.1006/gyno.2002.6769

P. Grigsby, B. Siegel, F. Dehdashti, and D. Mutch, Posttherapy surveillance monitoring of cervical cancer by FDG-PET, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.4, pp.907-920, 2003.
DOI : 10.1016/S0360-3016(02)04287-6

A. Orlacchio, O. Schillaci, E. Gaspari, D. Gatta, F. Danieli et al., Ruolo della 18F-FDG PET/TCms nella valutazione della risposta precoce al trattamento del linfoma di Hodgkin, La radiologia medica, vol.51, issue.7
DOI : 10.1007/s11547-012-0792-8

F. Day, E. Link, S. Ngan, T. Leong, K. Moodie et al., FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy, British Journal of Cancer, vol.10, issue.4, pp.498-504, 2009.
DOI : 10.1007/s11307-005-0003-6

G. Melton, W. Lavely, H. Jacene, R. Schulick, M. Choti et al., Efficacy of Preoperative Combined 18-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for Assessing Primary Rectal Cancer Response to Neoadjuvant Therapy, Journal of Gastrointestinal Surgery, vol.9, issue.1
DOI : 10.1007/s11605-007-0170-7

A. Maffione, A. Ferretti, G. Grassetto, E. Bellan, C. Capirci et al., Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.4, pp.853-64, 2013.
DOI : 10.1007/s00259-013-2357-3

C. Capirci, L. Rampin, P. Erba, F. Galeotti, G. Crepaldi et al., Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.10, pp.1583-93, 2007.
DOI : 10.1007/s00259-007-0426-1

G. Dedemadi and S. Wexner, Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate? Dig Dis Basel Switz, pp.109-126, 2012.

E. Laffon, X. Adhoute, H. De-clermont, and R. Marthan, Is Liver SUV Stable over Time in 18F-FDG PET Imaging?, Journal of Nuclear Medicine Technology, vol.39, issue.4, pp.258-63, 2011.
DOI : 10.2967/jnmt.111.090027